Pacira BioSciences, Inc. (NASDAQ:PCRX) received FDA clearance to market a new Smart Tip designed to access the medial branch ...

Pacira BioSciences PCRX announced that the FDA has cleared its application to market a new Smart Tip for the iovera system ...

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

A PAIN-RELIEF INNOVATION ... to prove a drug’s safety, effectiveness and quality. Accelerated drug approval: The agency released draft guidance describing how the FDA will consider a ...

New drug approved for treating chronic schizophrenia with fewer side effects. Could be beneficial for Black community.

The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...

A first-in-class pain med and blockbusters with new indications are just a few of the possible approvals to keep an eye on in ...

commented on the "significant number" of already-approved medications that were approved for new uses in 2024. One example is the weight-loss medication Wegovy, which was approved for ...

After thousands of complaints about complications, the FDA has issued an open letter to veterinarians to be alert to serious ...

Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.